The Methuselah Foundation
- Assets
- $21.1m
- Revenue
- $129.4m
- Investments
- $1.7m
- Employees
- 1
- Location
- Springfield, VA
- Founding
- 02/2002
- Data as of
- 12/2023
- EIN
- 54-2040344
Organization Overview
The Methuselah Foundation is located in Springfield, VA. The organization was established in 2002. According to its NTEE Classification (T12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Methuselah Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Methuselah Foundation generated $129.4m in total revenue. All expenses for the organization totaled $123.3m during the year ending 12/2023. While expenses have increased by 107.0% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Methuselah Foundation has awarded 39 individual grants totaling $13,856,333. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
METHUSELAH FOUNDATION WORKS TO ACCELERATE TECHNOLOGICAL BREAKTHROUGHS IN HEALTHY HUMAN LIFE EXTENSION THROUGH REGENERATIVE MEDICINE AND NUTRITION RESEARCH INITIATIVES START-UP INCUBATION AND OPEN INNOVATION CHALLENGES
Describe the Organization's Program Activity:
Part 3 - Line 4a
SENESCENCE RESEARCH INTO THE BIOLOGICAL PROCESS AND BIOMARKERS OF AGING AND DEVELOPMENT OF DISRUPTIVE REGENERATIVE MEDICINE BIOTECHNOLOGIES CELL THERAPIES AND SENESCENCE INHIBITING PHARMACEUTICAL PROTOCOLS
TISSUE ENGINEERING: ACCELERATING THE PRODUCTION AND PRESERVATION OF FUNCTIONAL HUMAN TISSUES THROUGH RESEARCH STARTUP INCUBATION AND PUBLIC COLLABORATION FRAMEWORKS. INCLUDES THE MANAGEMENT OF NASAS VASCULAR TISSUE CHALLENGE AN OPEN INNOVATION CHALLENGE FOR THE DEVELOPMENT OF THICK METABOLICALLY-FUNCTIONAL HUMAN VASCULARIZED ORGAN TISSUE IN A CONTROLLED LABORATORY ENVIRONMENT.
NUTRITION: FOSTERING THE CREATION OF BIOLOGICALLY ADAPTIVE FOOD AND MEDICINE PRODUCTION AND DELIVERY SYSTEMS. INCLUDES MANAGEMENT OF NASAS DEEP SPACE FOOD CHALLENGE AN INTERNATIONAL OPEN INNOVATION CHALLENGE FOR THE DEVELOPMENT OF EFFICIENT DYNAMIC FOOD PRODUCTION SYSTEMS FOR TERRESTRIAL AND SPACE APPLICATIONS
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
We Sheep Can Fly Gobel Dane B Program Management Services | 12/30/23 | $205,362 |
Methuselah Capital Management Program Management Services | 12/30/23 | $133,000 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $163,572,564 |
| Noncash contributions included in lines 1a–1f | $163,431,000 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $163,572,564 |
| Total Program Service Revenue | $106,731 |
| Investment income | $50,766 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$34,363,628 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $129,367,180 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $4,432,149 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $287,553 |
| Compensation of current officers, directors, key employees. | $43,133 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $23,966 |
| Payroll taxes | $14,112 |
| Fees for services: Management | $747,395 |
| Fees for services: Legal | $56,824 |
| Fees for services: Accounting | $44,400 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $3,961 |
| Office expenses | $5,394 |
| Information technology | $84,155 |
| Royalties | $0 |
| Occupancy | $45,812 |
| Travel | $129,629 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $97,127 |
| Interest | $464 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $5,857 |
| Insurance | $2,956 |
| All other expenses | $2,319 |
| Total functional expenses | $123,266,752 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $365,162 |
| Savings and temporary cash investments | $7,527,269 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $2,595 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $173,958 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $1,686,107 |
| Investments—program-related | $11,335,302 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $21,090,393 |
| Accounts payable and accrued expenses | $127,935 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $127,935 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $20,962,458 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $21,090,393 |
Grants Awarded
Over the last fiscal year, The Methuselah Foundation has awarded $4,432,149 in support to 5 organizations.
| Grant Recipient | Amount |
|---|---|
CENTER FOR CONTEMPORARY SCIENCES PURPOSE: Research | $60,000 |
HEALTHSPAN ACTION COALITION INC PURPOSE: Research | $50,000 |
ICHOR RESEARCH INSTITUTE INC PURPOSE: Research | $4,289,336 |
LONG LIFE LABS LLC PURPOSE: Research | $7,813 |
ORA BIOMEDICAL INC PURPOSE: Research | $25,000 |